Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.



MAKO Surgical: Another Earnings Beat in Store?

Don't let it get away!

Keep track of the stocks that matter to you.

Help yourself with the Fool's FREE and easy new watchlist service today.

Robotic surgical specialist MAKO Surgical (Nasdaq: MAKO  ) is set to kick off its fiscal 2012 with first-quarter earnings on Monday after the market closes.

Analysts are expecting MAKO to post revenue of $23.8 million, which would represent growth of roughly 83% compared with the $13 million in sales seen a year ago. The estimates range from as low as $22.9 million to as high as $25.8 million in sales. The company's net loss is expected to narrow to $0.20 per share, down from the $0.27 loss last time around.

In addition to keeping an eye on how many RIO systems were installed during the quarter, I'll also be looking at the metrics for MAKO's new Total Hip Arthroplasty, or THA, procedure. THA was commercially launched in September, and last quarter was the first time to see some numbers as THA procedures began, starting with 117 performed.

As of the end of last year, 44% of the domestic commercial installed base was locked and loaded for THA procedures, so the number of procedures performed should begin accelerating, although the first quarter is typically a seasonally tougher one, as patients' insurance deductibles reset at the beginning of the year.

I'll also be looking at MAKO's cash reserves and how much of it was burned during the quarter. On the last conference call, CFO Fritz LaPorte said the company expects to burn between $25 million and $30 million during 2012 and also said it was unlikely MAKO would need to tap capital markets for more dollars.

I'm also interested to hear management's thoughts on the Patient Protection and Affordable Care Act, or PPACA, and the new 2.3% tax that will be imposed on medical-device sales starting next year, and whether or not they think it will affect demand in any meaningful way. That 2.3% adds up when we're talking about a device that costs roughly three-quarters of a million dollars each.

MAKO is set to continue about its disruptive ways, following in the footsteps of Intuitive Surgical (Nasdaq: ISRG  ) , which just put up an earnings beat of its own recently. I think MAKO will follow suit on Monday.

MAKO has its fair share of risk, but if you're looking for more stable alternatives, don't miss this special free report on how to Secure Your Future With 9 Rock-Solid Dividend Stocks, one of which happens to be one of MAKO's larger rivals that's it's aiming to disrupt. It's totally free.

Fool contributor Evan Niu owns shares of MAKO Surgical, but he holds no other position in any company mentioned. Check out his holdings and a short bio. The Motley Fool owns shares of Intuitive Surgical and MAKO Surgical. Motley Fool newsletter services have recommended buying shares of MAKO Surgical and Intuitive Surgical. The Motley Fool has a disclosure policy. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. Try any of our Foolish newsletter services free for 30 days.

Read/Post Comments (5) | Recommend This Article (3)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On May 07, 2012, at 4:38 PM, verylargelarry wrote:

    MAKO is set to continue about its disruptive ways, following in the footsteps of Intuitive Surgical (Nasdaq: ISRG ) , which just put up an earnings beat of its own recently. I think MAKO will follow suit on Monday.

    And the results are in....MAKO loses 25% of its market value after failing to "beat."

    SA growth selections taking a beating recently.

  • Report this Comment On May 07, 2012, at 4:43 PM, merciway wrote:

    Thanks for nothing

  • Report this Comment On May 08, 2012, at 8:35 AM, hudsondusters wrote:

    Price got way ahead of the results. And they are borrowing money with warrants attached. So I'd say they did need to hit the capital markets.

  • Report this Comment On May 08, 2012, at 9:52 AM, dstb wrote:

    Ouch. Smack down today.

  • Report this Comment On May 08, 2012, at 11:20 AM, tokelau wrote:

    mr. Niu, it's not only MAKO where you miss the mark completely, I'm starting to wonder if you are up to your task, which is -imho- sharing sharp insight with MF's readers. On MF's video's you look very young. Zuckerberg is young, but he has proven himself.

Add your comment.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 1880149, ~/Articles/ArticleHandler.aspx, 10/21/2016 7:45:56 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 10 hours ago Sponsored by:
DOW 18,162.35 -40.27 -0.22%
S&P 500 2,141.34 -2.95 -0.14%
NASD 5,241.83 -4.58 -0.09%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

12/31/1969 7:00 PM
MAKO.DL $0.00 Down +0.00 +0.00%
MAKO Surgical CAPS Rating: ****
ISRG $681.82 Up +0.24 +0.04%
Intuitive Surgical CAPS Rating: ****